Drug interactions
Sipuleucel-t + Sorafenib
Severity: Minor
Sipuleucel-t and Sorafenib: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Sipuleucel-T depends on immune activation, and kinase inhibitors or other immunosuppressive anticancer drugs might blunt that response. Clinical data on sorafenib specifically are lacking.
What this interaction means in plain words
Sipuleucel-t and Sorafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Theoretical pharmacodynamic interference with immune cell activation; not well established.
What to do
Be aware of the theoretical effect when planning treatment sequence. Consider avoiding concurrent immunosuppressive therapy during the sipuleucel-T course if clinically feasible.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Sipuleucel-t and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Sorafenib
Frequently asked questions
Can I take Sipuleucel-t with Sorafenib?
MediHelp rates the interaction as minor. Sipuleucel-t and Sorafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Sipuleucel-T depends on immune activation, and kinase inhibitors or other immunosuppressive anticancer drugs might blunt that response. Clinical data on sorafenib specifically are lacking.
How serious is the interaction between Sipuleucel-t and Sorafenib?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Be aware of the theoretical effect when planning treatment sequence. Consider avoiding concurrent immunosuppressive therapy during the sipuleucel-T course if clinically feasible.
What other medicines interact with Sorafenib?
MediHelp also lists interactions of Sorafenib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sorafenib page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
